Re:Mechanism of hardening of the arteries and potential trea...
by dvfjsdhgfv on Tuesday June 11, 2019 @02:26PM
(#20158138)
This struck me as well. The only thing that comes to mind is the way to administer minocycline. But it's obvious that if the treatment works well, other researchers will find other ways to administer this drug, so I don't see a point. They probably follow a standard procedure to recoup the cost of research, but since they choose a generic drug, I wonder if there is a way to monetize it at all.
Re:Mechanism of hardening of the arteries and potential trea...
by et2o on Tuesday June 11, 2019 @07:33PM
(#20160471)
They can patent minocycline and it's derivatives.
If they made a brand name minocycline, no one would ever use it because it's already generic. However if they can make a derivative that is more efficacious (even if it's only slightly different), they can brand that and sell it under patent for a while.
Can anyone tell what was patented? I would assume not minocycline, but I've been surprised before about what could be patented.